Partner, Patent Attorney
Life Sciences


Our People

Our IP specialists work at all stage of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.

News & Insights

We want to keep you up to date with developments in the IP world and let you know what we are up to at Mewburn Ellis.

Read our blogs

Law & Practice Guides

We believe in making it easy for you to find the information that you want – and you can always contact us if you can’t find what you need.

Read our Law and Practice guides

Posts by Author

Blogs by Author

The majority of Robert’s work is in the biopharma sector, principally with companies undertaking drug discovery and development. He advises on all stages of a medicine’s lifecycle, from initial discovery through clinical trials to regulatory approval. Working closely with in-house IP teams and scientists, he has extensive experience of drafting and prosecution, global portfolio management and invention capture. He also helps clients negotiate IP agreements and performs due diligence.

Areas of Expertise

  • Antibody therapeutics – particularly antibody-drug conjugates in the oncology field (including immune-oncology)
  • Industrial fermentation – especially amino acid & bioethanol production
  • Biotherapeutic separation and purification technologies – in particular flow-filtration methods


In the UK and Europe, Robert’s clients are mainly biopharma companies involved in oncology. He also works with Korea-based biopharmas that focus on therapeutic proteins and industrial fermentation. His US clients include multinational biotechs that specialise in industrial fermentation.


Robert has a Masters in biochemistry from the University of Oxford and a Masters in philosophy from the University of Cambridge. He also has a PhD from Cambridge, which involved cellular developmental biology research. He joined Mewburn Ellis LLP in 2006, qualifying as a Chartered Patent Attorney in 2010 and a European Patent Attorney in 2011. He joined the partnership in 2015.

Robert spent several months living in Seoul while working with a firm of Korean patent attorneys, developing expertise in the Korean biopharma and patent sectors. He has presented many seminars on European IP practices to Korean patent attorneys and was the first European patent attorney to the KIPO biotechnology group. He has also written for the KPAA newsletter.

Robert is an Elected Member of the Society of Biology (MSB).